Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) has completed its Phase 1 study evaluating proprietary oral transmucosal film (OTF) DMT formulation VLS-01 in 74 healthy participants.
Cybin Inc. (NYSE: CYBN), a clinical-stage biotech company developing novel psychedelic-based mental health treatments, has completed dosing of the final participant cohort in the
A day after Rivian Automotive Inc (NASDAQ: RIVN) reported production and delivery numbers for the third quarter, CEO RJ Scaringe shared his thoughts on the road ahead, including increasing competition from
Singh's appointment comes in support of the Company's next evolution, which will be focused on investing in top talent, commencement of commercial operations, and investing in clinical research and development of plant
Spirit AeroSystems Holdings Inc (NYSE: SPR) has appointed Patrick M. Shanahan, a member of its Board of Directors, as interim President and Chief Executive Officer, effective immediately.
The company said Thomas C. Gentile no longer serves as President, Chief Executive Officer, and Director.